- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- hetero-1-1-1-1-mer
- Ligands
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x CA: CALCIUM ION(Non-covalent)
- 3 x MN: MANGANESE (II) ION(Non-covalent)
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x I7R: (4-{[(5S)-3-{4-[(E)-imino(4-methylpiperazin-1-yl)methyl]phenyl}-4,5-dihydro-1,2-oxazol-5-yl]methyl}piperazin-1-yl)acetic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lin, F.Y. et al., A general chemical principle for creating closure-stabilizing integrin inhibitors. Cell (2022)
- Release Date
- 2022-08-17
- Peptides
- Integrin alpha-IIb: A
Integrin beta-3: B
Fab heavy chain: C
Fab light chain: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
DC
ED
F